repealing the prescription drug affordability board.

HB 570 modifies New Hampshire's Prescription Drug Affordability Board (PDAB) by expanding the definition of "public payor" to include state-funded health plans and corrections department coverage. It adds an alternate board member appointed from an advisory council (with terms tied to council membership), sets a 2-year term for the board chair (elected by members), and extends the executive director position until June 2030 (previously limited to 2 years after initial hire). The bill does not repeal the PDAB but adjusts its structure, with estimated annual costs of $140,000-$153,000 for the executive director role funded by the General Fund. It takes effect 60 days after passage.